RxDoctor Payments Data

Greg Howes, MD

Neurological Surgery · Roanoke, VANPI 1801074661

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Medtronic at 55.4% of the total. Reporting peaked in 2021 at $995 and has fallen 65.0% since, to $348 in 2025.

$4,568in general payments, 2019–2025

Across 66 payments — averaging $69.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Johnson & Johnson$633
  • Si-bone, Inc.$296
  • Medical Device Business Services, Inc.$264
  • Stryker$240
  • Kuros Biosciences USA, Inc$212
  • plus $391 from 5 others
$193,505in research payments, 2019–2025

Across 58 payments — averaging $3336.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$174K
  • Globus Medical$12K
  • Medtronic$8K

What the payments were for

  • Travel & lodging$982%
  • Food & beverage$4,41997%
  • Entertainment$511%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,568 in reported general payments places this provider in the 60th percentile of 156 neurological surgery providers in Virginia.

See all neurological surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$190,934
Medicare patients
255
Services billed
617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin12$121
Oxycodone Hcl12$107

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Roanoke

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →